{"Abstract": [0], "Alzheimer\u2019s": [1], "disease": [2], "(AD)": [3], "stands": [4], "as": [5, 30, 45, 163], "the": [6, 46, 65, 73, 84, 128, 135, 141, 153, 172, 182, 200, 226], "predominant": [7], "form": [8], "of": [9, 27, 38, 76, 117, 146, 175, 185, 202, 232], "dementia,": [10], "presenting": [11], "significant": [12], "and": [13, 21, 33, 60, 71, 81, 107, 122, 130, 144, 157, 166, 188, 214, 229], "escalating": [14], "global": [15], "challenges.": [16], "Its": [17], "etiology": [18], "is": [19, 221], "intricate": [20], "diverse,": [22], "stemming": [23], "from": [24], "a": [25, 164], "combination": [26], "factors": [28], "such": [29, 44], "aging,": [31], "genetics,": [32], "environment.": [34], "Our": [35, 219], "current": [36, 173], "understanding": [37, 174], "AD": [39, 77, 160, 176, 192, 234], "pathologies": [40], "involves": [41], "various": [42], "hypotheses,": [43], "cholinergic,": [47], "amyloid,": [48], "tau": [49], "protein,": [50], "inflammatory,": [51], "oxidative": [52], "stress,": [53], "metal": [54], "ion,": [55], "glutamate": [56], "excitotoxicity,": [57], "microbiota-gut-brain": [58], "axis,": [59], "abnormal": [61], "autophagy.": [62], "Nonetheless,": [63], "unraveling": [64], "interplay": [66], "among": [67], "these": [68, 147], "pathological": [69], "aspects": [70], "pinpointing": [72], "primary": [74], "initiators": [75], "require": [78], "further": [79, 150], "elucidation": [80], "validation.": [82, 151], "In": [83], "past": [85], "decades,": [86], "most": [87], "clinical": [88, 186, 230], "drugs": [89, 102, 148, 161], "have": [90], "been": [91], "discontinued": [92], "due": [93], "to": [94, 222], "limited": [95], "effectiveness": [96], "or": [97], "adverse": [98], "effects.": [99, 113, 139], "Presently,": [100], "available": [101], "primarily": [103], "offer": [104], "symptomatic": [105], "relief": [106], "often": [108], "accompanied": [109], "by": [110, 127], "undesirable": [111], "side": [112], "However,": [114], "recent": [115, 197], "approvals": [116], "aducanumab": [118], "(": [119, 124], "1": [120], ")": [121, 126], "lecanemab": [123], "2": [125], "Food": [129], "Drug": [131], "Administration": [132], "(FDA)": [133], "present": [134], "potential": [136], "in": [137, 179, 199], "disrease-modifying": [138], "Nevertheless,": [140], "long-term": [142], "efficacy": [143], "safety": [145], "need": [149], "Consequently,": [152], "quest": [154], "for": [155, 191], "safer": [156], "more": [158], "effective": [159], "persists": [162], "formidable": [165], "pressing": [167], "task.": [168], "This": [169], "review": [170], "discusses": [171], "pathogenesis,": [177], "advances": [178], "diagnostic": [180], "biomarkers,": [181], "latest": [183], "updates": [184], "trials,": [187], "emerging": [189], "technologies": [190], "drug": [193], "development.": [194], "We": [195], "highlight": [196], "progress": [198], "discovery": [201], "selective": [203], "inhibitors,": [204, 206, 210], "dual-target": [205], "allosteric": [207], "modulators,": [208], "covalent": [209], "proteolysis-targeting": [211], "chimeras": [212], "(PROTACs),": [213], "protein-protein": [215], "interaction": [216], "(PPI)": [217], "modulators.": [218], "goal": [220], "provide": [223], "insights": [224], "into": [225], "prospective": [227], "development": [228], "application": [231], "novel": [233], "drugs.": [235]}